Engineering dendritic cell vaccines to improve cancer immunotherapy

Caleb R Perez1, Michele De Palma2

  • 1Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), CH-1015, Lausanne, Switzerland.

Nature Communications
|November 29, 2019
PubMed

Related Concept Videos